Search research articles
Contact Us
Filters
Showing results (981-990 of 1,003) with videos related to
Page
of 101
Sort By:
Leukemia Research
|
December 9, 2015
Dasatinib first-line: Multicentric Italian experience outside clinical trials
Massimo Breccia, Fabio Stagno, Luigiana Luciano, et al.
Oncotarget
|
November 21, 2017
The <i>hOCT1</i> and <i>ABCB1</i> polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia
Sara Galimberti, Cristina Bucelli, Elena Arrigoni, et al.
Molecular Pharmaceutics
|
December 16, 2024
Current State and New Horizons in Applications of Physiologically Based Biopharmaceutics Modeling (PBBM): A Workshop Report
Christer Tannergren, Sumit Arora, Andrew Babiskin, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery
|
February 17, 2024
Delphi consensus statement for understanding and managing the subcostal hernia: subcostal hernias collaborative report (scholar study)
S J Baig, G V Kulkarni, P Priya, et al.
Cancer Medicine
|
February 17, 2021
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study
Michele Malagola, Alessandra Iurlo, Elisabetta Abruzzese, et al.
Drugs & Aging
|
May 18, 2013
Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study
Roberto Latagliata, Dario Ferrero, Alessandra Iurlo, et al.
Leukemia Research
|
July 23, 2014
Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival
Massimo Breccia, Luigiana Luciano, Roberto Latagliata, et al.
Frontiers in Pharmacology
|
April 10, 2023
Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study
A Iurlo, D Cattaneo, D Consonni, et al.
International Journal of Cardiology
|
March 17, 2022
Clinical characteristics and 30-day outcomes in patients with acute decompensated heart failure: Results from Indian College of Cardiology National Heart Failure Registry (ICCNHFR)
P B Jayagopal, Sridhar L Sastry, Veena Nanjappa, et al.
Cancer Research
|
May 2, 2023
β-Catenin-Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
Dipika R Mohan, Kleiton S Borges, Isabella Finco, et al.
Page
of 101
Search research articles
Search
Showing results (981-990 of 1,003) with videos related to
Sort By:
Page
of 101
Leukemia Research
|
December 9, 2015
Dasatinib first-line: Multicentric Italian experience outside clinical trials
Massimo Breccia, Fabio Stagno, Luigiana Luciano, et al.
Oncotarget
|
November 21, 2017
The <i>hOCT1</i> and <i>ABCB1</i> polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia
Sara Galimberti, Cristina Bucelli, Elena Arrigoni, et al.
Molecular Pharmaceutics
|
December 16, 2024
Current State and New Horizons in Applications of Physiologically Based Biopharmaceutics Modeling (PBBM): A Workshop Report
Christer Tannergren, Sumit Arora, Andrew Babiskin, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery
|
February 17, 2024
Delphi consensus statement for understanding and managing the subcostal hernia: subcostal hernias collaborative report (scholar study)
S J Baig, G V Kulkarni, P Priya, et al.
Cancer Medicine
|
February 17, 2021
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study
Michele Malagola, Alessandra Iurlo, Elisabetta Abruzzese, et al.
Drugs & Aging
|
May 18, 2013
Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study
Roberto Latagliata, Dario Ferrero, Alessandra Iurlo, et al.
Leukemia Research
|
July 23, 2014
Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival
Massimo Breccia, Luigiana Luciano, Roberto Latagliata, et al.
Frontiers in Pharmacology
|
April 10, 2023
Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study
A Iurlo, D Cattaneo, D Consonni, et al.
International Journal of Cardiology
|
March 17, 2022
Clinical characteristics and 30-day outcomes in patients with acute decompensated heart failure: Results from Indian College of Cardiology National Heart Failure Registry (ICCNHFR)
P B Jayagopal, Sridhar L Sastry, Veena Nanjappa, et al.
Cancer Research
|
May 2, 2023
β-Catenin-Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
Dipika R Mohan, Kleiton S Borges, Isabella Finco, et al.
Page
of 101